MSCI (MSCI) Chief Product Officer awarded 3,158 performance-based RSUs

(Neutral)

Form Type

Rhea-AI Filing Summary

MSCI Inc.’s Chief Product Officer, Alvise J. Munari, received a new equity grant in the form of restricted stock units. On January 30, 2026, he was awarded 3,158 shares of common stock at a price of $0 per share, increasing his directly owned stake to 33,986 shares.

The award consists of RSUs that are expected to vest and convert to shares on the third anniversary of the grant date. The final number of shares that vest will range from 100% to 130% of the target RSUs, depending on achievement of a specified performance metric for MSCI’s 2026 fiscal year.

Insider Trade Summary

Net Buyer: 3,158 shares

Net Buy 1 txn

Insider Munari Alvise J.

Role Chief Product Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	3,158	$0.00	$0.00

Holdings After Transaction: Common Stock — 33,986 shares (Direct)

Footnotes (1)

F1. Restricted stock units ("RSUs") that are expected to vest and convert to shares on the third anniversary of the grant date. The final number of shares issued upon vesting will be between 100% and 130% of the target number of RSUs based on achievement of a performance metric for the for the 2026 fiscal year (January 1, 2026 through December 31, 2026).

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 02/03/2026 - 04:01 PM

FAQ

What insider transaction did MSCI (MSCI) report for January 30, 2026?

MSCI reported an equity grant to its Chief Product Officer on January 30, 2026. Alvise J. Munari received 3,158 restricted stock units of MSCI common stock, awarded at $0 per share, increasing his directly held position to 33,986 shares.

Who is the insider involved in this MSCI (MSCI) Form 4 filing?

The insider is Alvise J. Munari, MSCI’s Chief Product Officer. He is an officer but not a director or 10% owner. The filing reflects a grant of 3,158 restricted stock units that will vest based on performance and time.

How many MSCI shares were granted to the Chief Product Officer in this filing?

The Chief Product Officer received 3,158 shares of MSCI common stock through restricted stock units. These RSUs were granted at a price of $0 per share and, after the grant, he directly beneficially owned a total of 33,986 shares.

What are the vesting terms of the MSCI (MSCI) restricted stock units granted?

The restricted stock units are expected to vest and convert to shares on the third anniversary of the grant date. The actual shares issued will be between 100% and 130% of the target RSUs, depending on a 2026 fiscal year performance metric.

How is performance measured for the MSCI (MSCI) RSU award in this Form 4?

The final number of shares from the RSU award depends on a performance metric for MSCI’s 2026 fiscal year, running from January 1, 2026 through December 31, 2026. Based on performance, vesting can range from 100% to 130% of target units.

Does this MSCI (MSCI) Form 4 involve stock sales by the insider?

No, the Form 4 reflects an acquisition of restricted stock units rather than a sale. The Chief Product Officer was granted 3,158 RSUs at $0 per share, increasing his directly owned MSCI common stock to 33,986 shares after the reported transaction.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Munari Alvise J.

(Last)

(First)

(Middle)

MSCI INC.

7 WORLD TRADE CENTER, 250 GREENWICH ST.

(Street)

NEW YORK

10007

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
MSCI Inc. [ MSCI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Product Officer

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	01/30/2026		A		3,158⁽¹⁾	A	$0	33,986	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Restricted stock units ("RSUs") that are expected to vest and convert to shares on the third anniversary of the grant date. The final number of shares issued upon vesting will be between 100% and 130% of the target number of RSUs based on achievement of a performance metric for the for the 2026 fiscal year (January 1, 2026 through December 31, 2026).

Remarks:

	/s/ Cecilia Aza, attorney-in-fact	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR